NYSEARCA:CUR - NYSE Arca - US64127R3021
1.52
-0.31 (-16.94%)
The current stock price of CUR is 1.52 null. In the past month the price increased by 4.83%. In the past year, price decreased by -86.43%.
NEURALSTEM's patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The Company expects that its first Investigational New Drug application will be for the treatment of Ischemic Paraplegia, a form of paraplegia that sometimes results from the surgery to repair aortic aneurysms and for which there is no effective treatment.
NEURALSTEM INC
20271 Goldenrod Lane
Germantown MD 20876
CEO: Kenneth Carter
Phone: 301-366-4841
The current stock price of CUR is 1.52 null. The price decreased by -16.94% in the last trading session.
The exchange symbol of NEURALSTEM INC is CUR and it is listed on the NYSE Arca exchange.
CUR stock is listed on the NYSE Arca exchange.
NEURALSTEM INC (CUR) has a market capitalization of 3.19M null. This makes CUR a Nano Cap stock.
NEURALSTEM INC (CUR) has a resistance level at 1.53. Check the full technical report for a detailed analysis of CUR support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CUR does not pay a dividend.
NEURALSTEM INC (CUR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.37).
ChartMill assigns a technical rating of 1 / 10 to CUR. When comparing the yearly performance of all stocks, CUR is a bad performer in the overall market: 97.87% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to CUR. CUR has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months CUR reported a non-GAAP Earnings per Share(EPS) of -5.37. The EPS decreased by -858.93% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -43516.23% | ||
ROA | -190.29% | ||
ROE | N/A | ||
Debt/Equity | 0 |